Clinical Trial Update: Higher Dose of Rekovelle in Oocyte Donors [Phase 2]

View source ↗

Summary

Phase 2 study updating higher dose of Rekovelle in oocyte donors for IVF has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• In Vitro Fertilization
• Infertility

Drugs mentioned

• Rekovelle (follitropin delta)

Snippet

Sponsor: IVI Madrid | Conditions: IVF | Phase 2 | Status: COMPLETED